Influence of Beta-Naphthoflavone on 7,12-Dimethylbenz(a)anthracene Metabolism, DNA Adduction, and Tumorigenicity in Rainbow Trout
Public Domain
-
2000/10/01
-
Details
-
Personal Author:Alexander D ; Bailey G ; Baird W ; Harttig U ; Hendricks J ; Miller MR ; Reddy AP ; Stamm SC ; Weimer TL
-
Description:Metabolism, DNA adduction, and tumor induction by 7,12-dimethylbenz(a)anthracene (DMBA) were examined in cultured trout liver cells and in vivo in trout. Modulating CYP1A1 activity indicated this enzyme plays a significant role in metabolizing DMBA to water-soluble compounds in isolated trout liver cells. The major DMBA metabolites identified in trout liver cells were 10-, 11-, 8,9-, and 5,6-DMBA dihydrodiols, and DMBA, 2- or 3- or 4-phenol; 7-OH-methyl-12-methyl-benz(a)anthracene and 12-OH-methyl-7-methyl-benz(a)anthracene were minor metabolites. A very small amount of DMBA-3,4-dihydrodiol was detected, and polar metabolites, which did not migrate with any DMBA metabolite standards, were observed. Incubating trout hepatocytes with DMBA-3,4-dihydrodiol produced three prominent, nonpolar adducts indistinguishable from those in mouse embryo cells. However, DMBA-DNA adducts, formed in trout in vivo or in trout liver cells exposed to DMBA, were predominantly more polar than those formed in mouse embryo fibroblasts, and levels of DMBA-DNA adducts formed in trout liver cells were not significantly altered by modulating CYP1A1 activity. No significant repair of DMBA-DNA adducts was detected in cultured trout liver cells over a 48-h period, supporting previous studies indicating that fish are less efficient than mammals in repairing polyaromatic hydrocarbon DNA adducts, Compared to animals receiving DMBA alone, beta-naphthoflavone pretreatment in vivo did not affect hepatic CYP1A1, DMBA-DNA adducts, nor hepatic tumor response; but did significantly reduce tumor response in two other target organs. These results collectively indicate that DMBA bioactivation to DNA-binding metabolites in trout liver cells and mouse embryo cells predominantly involve different metabolic pathways to form the DNA-binding intermediates. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:217-228
-
Volume:57
-
Issue:2
-
NIOSHTIC Number:nn:20032338
-
Citation:Toxicol Sci 2000 Oct; 57(2):217-228
-
Contact Point Address:MR Miller, Department of Biochemestry, West Virginia University Health Sciences Center, POB 9142, Morgantown, WV 26506
-
Email:mmiller@hsc.wvu.edu
-
Federal Fiscal Year:2001
-
Peer Reviewed:True
-
Source Full Name:Toxicological Sciences
-
Collection(s):
-
Main Document Checksum:urn:sha-512:9f35061a8f7c1fe64980668ec9f8f66a4f2e709c54e4f1111ba4d8e2088de7627f2c6cc049b989955edbdacad435a12ac6e3804b7b7e09e8abbc32b34f3d0eac
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like